Skip to content

The Beauty Health Company SKIN Amortization Of Financing Costs

Amortization Of Financing Costs at other companies

Helen Of Troy logo
Helen Of TroyHELE

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's amortization of financing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's amortization of financing costs?
The Beauty Health Company (SKIN) reported amortization of financing costs of $1.01M in Q1 2026.
How has The Beauty Health Company's amortization of financing costs changed year-over-year?
The Beauty Health Company's amortization of financing costs increased by 28.5% year-over-year, from $786K to $1.01M.
What is the long-term trend for The Beauty Health Company's amortization of financing costs?
Over 3 years (2022 to 2025), The Beauty Health Company's amortization of financing costs has grown at a -4.9% compound annual growth rate (CAGR), from $4.23M to $3.64M.
What does amortization of financing costs mean?
Represents the non-cash expense related to the amortization of costs incurred to obtain debt financing, such as legal fees and underwriting commissions. These costs are spread over the term of the associated debt instrument to reflect the true cost of borrowing.